Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Cloud platform Packet opens KC office after $25M funding round in New York
New York-based Packet’s newly established Kansas City office is expected to take full advantage of the area’s wealth of tech talent, said Ihab Tarazi. “There is actually a very good technical base in Kansas City — so here’s validation of that,” said Tarazi, chief technology officer at the cloud infrastructure firm committed to “building a…
Fast track Missouri Hyperloop: Bipartisan support for 670-mph travel builds speed
It isn’t just a pipe dream. The arrival of bipartisan state and federal support for high-speed, cross-region travel means the much-anticipated Missouri Hyperloop project continues to shoot forward, Ryan Weber said. “For businesses, this could be a huge opportunity to create a new industry, attract new businesses and leverage a much larger workforce,” Weber, KC…
Skip restaurant lines (and downloading another app) with text-based ordering
In an increasingly automated world, American consumers are experiencing app exhaustion while continuing to need innovative solutions to address daily pain points like waiting in lines at their favorite restaurants, said Eric Tucker. “People are tired of downloading apps,” said Tucker, founder of KC-based Digital Baron, which delivers Skip, an app-less mobile and pay platform.…
Cleaner, more durable design: Future of construction is already Built, says Andrè Davis
Built Interior Construction is “precision-cutting” cities of the future by injecting innovation into the slow-moving construction industry, said Andrè Davis. “The challenges in our industry is that construction methods are so archaic,” said Davis, business development executive at the Kansas City interior construction firm, founded in 2016 by Russ Branden, David Anderson, and Mark Brandmeyer.…